BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Manufacturing

OBiO Launches GMP Facility Intelli-M for Rapid Delivery of Innovative Therapies

The launch of the new base in Shanghai will enhance OBiO's production and service capabilities in both China and the United States...

September 28, 2023 | News

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

The opening will add drug substance and drug product capacity, with end-to-end services for diversified vaccines that will accelerate global clients' proje...

September 27, 2023 | News

Merck to Become First Provider to Offer Fully Integrated mRNA Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...

September 27, 2023 | News

4 Ways to Increase Operational Performance

...

September 26, 2023 | News

Chime Biologics Partners with Korea Kings Pharm for Biosimilar Launch

Chime Biologics, a leading CDMO that enables its partners' success in biologics, announced a strategic cooperation with Kings Pharm. According to the agre...

September 26, 2023 | News

Chime Biologics Partners with Panolos Bioscience for Multi-specific Protein Development

Chime Biologics, a leading CDMO that enables biologic therapeutics development announced a strategic cooperation agreement with Panolos Bioscience, a South...

September 25, 2023 | News

WuXi XDC Launches New Commercial Manufacturing Facilities

New commercial facilities offer one-stop manufacturing services for antibody intermediates, bioconjugate drug substance and drug product Do...

September 21, 2023 | News

South Korea's ST Pharm Marks Milestone with Oligonucleotide Facility Ceremony

To diversify its operational scope, the new facility will be designed to accommodate different scales of production. Initially, it will introduce three new...

September 19, 2023 | News

Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...

September 18, 2023 | News

Lonza Upgrades MODA-ES® Module for Enhanced Electronic Batch Record Execution

The MODA-ES® Module v4.0 is an electronic batch record solution that helps pharmaceutical customers to expedite batch release by minimizing p...

September 11, 2023 | News

Samsung Biologics appoints new leadership to oversee quality and regulatory affairs

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced the appointments of Gail Ward...

August 24, 2023 | News

Honeywell & Recipharm Accelerate Low-Warming Inhaler Development

Honeywell (Nasdaq: HON) and global contract development and manufacturing organization (CDMO) Recipharm have today announced a commercial p...

August 21, 2023 | News

WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services

Under the collaboration, Boostimmune will have access to WuXi Biologics' integrated discovery services and extensive expertise in antibody discovery, lead ...

August 11, 2023 | News

Bora Pharmaceuticals Introduces State-of-the-Art Facility in Taiwan to Produce Ophthalmic Products

Officially opened by Bora Pharmaceuticals CEO Bobby Sheng and President of Taiwan Operations Tom Chang, the facility will provide Bora’s customers wi...

August 07, 2023 | News

Stay Connected